Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk

NCT ID: NCT02705924

Last Updated: 2021-11-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-30

Study Completion Date

2021-09-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Young female counselees (18-40 years) belonging to HBOC families with a known mutation on BRCA-genes or not, receive a lot of information regarding their cancer risk. Information sources are numerous and sometimes contradictory. Unfortunately, these women face these issues at a key moment of there identity construction (self, relationship, sexuality) while they are not yet concerned by health prevention measures. A special psychoeducational intervention was designed to help these women to better cope with these difficulties.

Intervention consists in a week-end session in a thermal center (SPA) during which they will attend short conferences given by specialists (prevention measures, prophylactic surgery, assisted procreation, epidemiology...) and participate to role games and group sharing.

Intervention will be evaluated using self-questionnaires completed before intervention and during the following year.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: Young women exposed to a high hereditary breast/ovaries cancer (HBOC) risk are particularly vulnerable: they are ignored by health prevention measures; they are embedded in a stream of contradictory information ( medicine, media, internet); they may feel concerned by surgical prevention issues at a key moment of there identity construction (self, relationship, sexuality). A special psychoeducational intervention was designed to help these women to better cope with these difficulties.

Methods/design: the study consists in a prospective randomized trial including childless young female counselees (18-40 years) of CCC Jean Perrin oncogenetics department, belonging to HBOC families either BRCA-mutated or not. They will be invited to attend a weekend group session in a SPA resort and participate to a series of short expert conferences and to focus group activities (group sharing, Moreno role game) supervised by a psychotherapist. Two sessions separated by a 6-month delay (waiting list) will enable us to evaluate the intervention effect, by comparing the evolution of questionnaires scores between inclusion and 6-month post-intervention. Main end-point is an increase of the Hert Hope Inventory of at least one standard deviation. Secondary endpoints investigate self-esteem, anxiety-trait, anxiety-state, ways of coping and quality of life. Participants will be randomized 1:1 to the first or the second session so that groups are comparable. Session will be cost-free for participants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hereditary Breast and Ovarian Cancer Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Psychoeducational intervention

group participating to the first psychoeducational intervention: it consists in a week-end session in a SPA center including several conferences about HBOC familial risk, cancer prevention, prophylactic possibilities (surgery), recommendations about nutrition and physical activity a risk modulators, assisted medical procreation and embryo selection, social support...). Besides conferences, Moreno role games and group sharing are organized under the supervision of a psychotherapist.

Group Type EXPERIMENTAL

psychoeducation

Intervention Type BEHAVIORAL

Participants will attend conferences where experts present the state of the art in various domains:

* Latest knowledge in oncogenetics
* Recommendations and morbidity of prophylactic breast surgeries and annexectomy
* Epidemiology of HBOC and comparative mortality risks with other syndromes/life habits
* How to perform the periodic breast screening
* Assisted medical procreation and embryo selection
* Importance of nutrition and physical activity as risk modulator
* Life habits: how one can increase or lower the cancer risk (tobacco, alcohol...)?
* Description of the assistance program (GENAUV) to help counselees exposed to a high cancer risk follow their medical screening.

The remaining time after this information, i.e. about half of the week-end, will comprise group activities, in particular role games (Moreno psychodrama approach) and group sharing under the supervision of a psychotherapist.

Waiting list

delayed intervention: group participating to the second psychoeducational intervention (6 months later). Intervention is same as in the intervention arm but it is delayed. Because questionnaires are completed before this second intervention in both arms and allocation to arms are randomized, it represents an adequate control group.

Group Type OTHER

psychoeducation

Intervention Type BEHAVIORAL

Participants will attend conferences where experts present the state of the art in various domains:

* Latest knowledge in oncogenetics
* Recommendations and morbidity of prophylactic breast surgeries and annexectomy
* Epidemiology of HBOC and comparative mortality risks with other syndromes/life habits
* How to perform the periodic breast screening
* Assisted medical procreation and embryo selection
* Importance of nutrition and physical activity as risk modulator
* Life habits: how one can increase or lower the cancer risk (tobacco, alcohol...)?
* Description of the assistance program (GENAUV) to help counselees exposed to a high cancer risk follow their medical screening.

The remaining time after this information, i.e. about half of the week-end, will comprise group activities, in particular role games (Moreno psychodrama approach) and group sharing under the supervision of a psychotherapist.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

psychoeducation

Participants will attend conferences where experts present the state of the art in various domains:

* Latest knowledge in oncogenetics
* Recommendations and morbidity of prophylactic breast surgeries and annexectomy
* Epidemiology of HBOC and comparative mortality risks with other syndromes/life habits
* How to perform the periodic breast screening
* Assisted medical procreation and embryo selection
* Importance of nutrition and physical activity as risk modulator
* Life habits: how one can increase or lower the cancer risk (tobacco, alcohol...)?
* Description of the assistance program (GENAUV) to help counselees exposed to a high cancer risk follow their medical screening.

The remaining time after this information, i.e. about half of the week-end, will comprise group activities, in particular role games (Moreno psychodrama approach) and group sharing under the supervision of a psychotherapist.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants must belong to HBOC families,
* aged between 18 and 40 years
* Single or couple with a desire to have a child
* without any personal history of cancer.
* must have consulted at the oncogenetics department of the CCC Jean Perrin
* tested for a BRCA mutation.
* mutation carrier in case of a known familial BRCA mutation, else exposed to a high familial HBOC risk (Eisinger score ≥ 6 or Manchester score ≥ 16)
* must live in Auvergne region (middle France)
* signed an informed consent before inclusion.

Exclusion Criteria

* pregnant women
* person who cannot answer questionnaires: language difficulties and/or cannot write in French correctly.
* no possible connection to our web-site
* psychiatric troubles and/or ongoing treatments preventing from a week-end stay in a SPA resort
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondation de l'Avenir et la MASFIP, Paris - France

UNKNOWN

Sponsor Role collaborator

Centre Jean Perrin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yves-Jean BIGNON

Role: PRINCIPAL_INVESTIGATOR

Centre Jean Perrin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Jean Perrin

Clermont-Ferrand, Puy De Dome, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Cousson-Gelie F, Cosnefroy O, Christophe V, Segrestan-Crouzet C, Merckaert I, Fournier E, Libert Y, Lafaye A, Razavi D. The Ways of Coping Checklist (WCC): validation in French-speaking cancer patients. J Health Psychol. 2010 Nov;15(8):1246-56. doi: 10.1177/1359105310364438. Epub 2010 Aug 27.

Reference Type BACKGROUND
PMID: 20801945 (View on PubMed)

Bruchon-Schweitzer M, Cousson F, Quintard B, Nuissier J, Rascle N. French adaptation of the Ways of Coping Checklist. Percept Mot Skills. 1996 Aug;83(1):104-6. doi: 10.2466/pms.1996.83.1.104.

Reference Type BACKGROUND
PMID: 8873181 (View on PubMed)

Herth K. Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs. 1992 Oct;17(10):1251-9. doi: 10.1111/j.1365-2648.1992.tb01843.x.

Reference Type BACKGROUND
PMID: 1430629 (View on PubMed)

Folkman S, Lazarus RS. An analysis of coping in a middle-aged community sample. J Health Soc Behav. 1980 Sep;21(3):219-39. No abstract available.

Reference Type BACKGROUND
PMID: 7410799 (View on PubMed)

Levenson H. Multidimensional locus of control in psychiatric patients. J Consult Clin Psychol. 1973 Dec;41(3):397-404. doi: 10.1037/h0035357. No abstract available.

Reference Type BACKGROUND
PMID: 4803272 (View on PubMed)

Loas G, Dardennes R, Dhee-Perot P, Leclerc V, Fremaux D. [Operationalization of the "locus of control" concept: translation and first validation study of the Levenson control scale (IPC: the internal powerful others and chance scale)]. Ann Med Psychol (Paris). 1994 Aug-Sep;152(7):466-9. French.

Reference Type BACKGROUND
PMID: 7978779 (View on PubMed)

Power M, Harper A, Bullinger M. The World Health Organization WHOQOL-100: tests of the universality of Quality of Life in 15 different cultural groups worldwide. Health Psychol. 1999 Sep;18(5):495-505. doi: 10.1037//0278-6133.18.5.495.

Reference Type BACKGROUND
PMID: 10519466 (View on PubMed)

Leplege A, Reveillere C, Ecosse E, Caria A, Riviere H. [Psychometric properties of a new instrument for evaluating quality of life, the WHOQOL-26, in a population of patients with neuromuscular diseases]. Encephale. 2000 Sep-Oct;26(5):13-22. French.

Reference Type BACKGROUND
PMID: 11192800 (View on PubMed)

Herth K. Enhancing hope in people with a first recurrence of cancer. J Adv Nurs. 2000 Dec;32(6):1431-41. doi: 10.1046/j.1365-2648.2000.01619.x.

Reference Type RESULT
PMID: 11136411 (View on PubMed)

Kwiatkowski F, Gay-Bellile M, Dessenne P, Laquet C, Boussion V, Beguinot M, Petit MF, Gremeau AS, Verlet C, Chaptal C, Broult M, Jouvency S, Duclos M, Bignon YJ. BRACAVENIR: an observational study of expectations and coping in young women with high hereditary risk of breast and ovarian cancer. Hered Cancer Clin Pract. 2019 Feb 27;17:7. doi: 10.1186/s13053-019-0107-7. eCollection 2019.

Reference Type DERIVED
PMID: 30858899 (View on PubMed)

Kwiatkowski F, Dessenne P, Laquet C, Daures JP, Gay-Bellile M, Bignon YJ. BRACAVENIR - impact of a psychoeducational intervention on expectations and coping in young women (aged 18-30 years) exposed to a high familial breast/ovarian cancer risk: study protocol for a randomized controlled trial. Trials. 2016 Oct 21;17(1):509. doi: 10.1186/s13063-016-1642-4.

Reference Type DERIVED
PMID: 27769293 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BRACAVENIR

Identifier Type: -

Identifier Source: org_study_id